Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $99.22 million. The enterprise value is $114.88 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 72.95 million shares outstanding. The number of shares has increased by 10.31% in one year.
| Current Share Class | 72.95M |
| Shares Outstanding | 72.95M |
| Shares Change (YoY) | +10.31% |
| Shares Change (QoQ) | +0.79% |
| Owned by Insiders (%) | 42.85% |
| Owned by Institutions (%) | 6.73% |
| Float | 35.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 63.91 |
| P/TBV Ratio | 75.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of 13.97.
| Current Ratio | 0.61 |
| Quick Ratio | 0.48 |
| Debt / Equity | 13.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -265.02% and return on invested capital (ROIC) is -59.03%.
| Return on Equity (ROE) | -265.02% |
| Return on Assets (ROA) | -50.05% |
| Return on Invested Capital (ROIC) | -59.03% |
| Return on Capital Employed (ROCE) | -149.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$703,405 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.21% in the last 52 weeks. The beta is 3.29, so Vivani Medical's price volatility has been higher than the market average.
| Beta (5Y) | 3.29 |
| 52-Week Price Change | -6.21% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 43.71 |
| Average Volume (20 Days) | 248,628 |
Short Selling Information
The latest short interest is 360,370, so 0.49% of the outstanding shares have been sold short.
| Short Interest | 360,370 |
| Short Previous Month | 628,250 |
| Short % of Shares Out | 0.49% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 0.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.21M |
| Pretax Income | -26.03M |
| Net Income | -26.03M |
| EBITDA | -26.81M |
| EBIT | -27.21M |
| Earnings Per Share (EPS) | -$0.44 |
Full Income Statement Balance Sheet
The company has $2.63 million in cash and $18.29 million in debt, giving a net cash position of -$15.67 million or -$0.21 per share.
| Cash & Cash Equivalents | 2.63M |
| Total Debt | 18.29M |
| Net Cash | -15.67M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 1.31M |
| Book Value Per Share | 0.02 |
| Working Capital | -2.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$23.41 million and capital expenditures -$1.20 million, giving a free cash flow of -$24.61 million.
| Operating Cash Flow | -23.41M |
| Capital Expenditures | -1.20M |
| Free Cash Flow | -24.61M |
| FCF Per Share | -$0.34 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Vivani Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.31% |
| Shareholder Yield | -10.31% |
| Earnings Yield | -26.23% |
| FCF Yield | -24.80% |
Analyst Forecast
The average price target for Vivani Medical is $4.00, which is 194.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 194.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |